chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Interchange of vaccine products
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; Dose #1: Pfizer/ Dose#2: Pfizer/ Dose #3: Pfizer/ Dose #4: Moderna; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 66-year-old male patient received bnt162b2 (BNT162B2), on 26Mar2021 as dose 1, single (Lot number: ER8727), on 18Apr2021 as dose 2, single (Lot number: EW0161) and on 09Nov2021 as dose 3 (booster), single (Lot number: 320308D) at the age of 64 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 13Jun2022 as dose 4 (booster), single (Lot number: 014B22A) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. No known allergies. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 13Jun2022, outcome "recovered", described as "Dose #1: Pfizer/ Dose#2: Pfizer/ Dose #3: Pfizer/ Dose #4: Moderna"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 26Oct2023 to 31Oct2023.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Blood pressure abnormal, Facial paresis, Muscular weakness, Nervous system disorder
Clinical narrative: bilateral and upper extremities weakness, partial facial; bilateral and upper extremities weakness, partial facial; blood pressure issues; presenting neurological issues; Initial information received on 09-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional (nurse).  This case involves a 35 years old female patient who experienced bilateral and upper extremities weakness, partial facial, bilateral and upper extremities weakness, partial facial, blood pressure issues and presenting neurological issues after receiving vaccine Influenza Vaccine (Quadrivalent).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 28-Oct-2023, the patient received 0.5 ml dose of suspect Influenza Vaccine (Quadrivalent) produced by unknown manufacturer, formulation: Injection of lot UT8109KA via intramuscular route in the right deltoid for immunization.  On 28-Oct-2023, the patient developed bilateral and upper extremities weakness, partial facial (muscular weakness) (facial paresis), blood pressure issues (blood pressure abnormal) and presenting neurological issues (nervous system disorder) (latency: same day) following the administration of Influenza vaccine (Quadrivalent).  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for all events.  At time of reporting, the outcome was Not Recovered / Not Resolved for all events.
Sex: F
Vaccine: COVID19, FLU4, RVX
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: mistakenly given fluzone hd with no reported adverse event; after the vaccine had been administered that she already received a flu shot from her doctor with no reported adverse event; Initial information received from country on 10-Nov-2023 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves Elderly female patient who was mistakenly given Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent] with no reported adverse event as the patient came in to get COVID, Pneumonia and RSV vaccines and after the Vaccine had been administered that she already received a flu shot from her doctor   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of 0.7 ml of suspect Influenza Quadrival A-B High Dose Hv Vaccine (lot: U8138AA and expiry date: 30-Jun-2023) (strength and formulation unknown) in unknown administration site for Immunization along with co- suspect vaccines Pnemonia, RSV vaccine and COVID-19 vaccine  not produced by Sanofi Pasteur (strength, batch number, formulation, expiry date unknown) via unknown route in unknown administration site for prophylactic vaccination (Immunization) .  On an unknown date the patient developed a non-serious mistakenly given fluzone hd with no reported adverse event (wrong product administered) and after the vaccine had been administered that she already received a flu shot from her doctor with no reported adverse event (extra dose administered) (unknown latency).  It was reported that Caller stated that the patient was mistakenly given FLUZONE HD even though the technician verified which vaccines were being given and patient agreed. Caller stated that the patient stated after the vaccine had been administered that she already received a flu shot from her doctor on Tuesday, 07-Nov-2023 so patient has now received two flu vaccines. Pharmacist wants to know if there is anything that they should watch out for.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Module of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness, Illness, Vomiting
Clinical narrative: DIZZY; SICK; HAVING CHILLS; THROWING UP; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 2022 for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced dizzy, sick, having chills, and throwing up. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from throwing up, having chills, dizzy, and sick. This report was non-serious.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Injection site pain
Clinical narrative: Caller has had three other shots with Moderna with no serious reactions other than soreness at the sight; Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) and INJECTION SITE PAIN (Caller has had three other shots with Moderna with no serious reactions other than soreness at the sight) in a 77-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 vaccination.     The patient's past medical history included Stroke (medications for his stroke - Amlodipine, Clopidogrel 75, Atorvastatin). Previously administered products included for Drug use for unknown indication: Caller got the flu shot 4 weeks before. Past adverse reactions to the above products included No adverse reaction with Caller got the flu shot 4 weeks before.   On an unknown date, the patient received third dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form and first dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On 13-Aug-2022, the patient experienced COVID-19 (Covid-19). On an unknown date, the patient experienced INJECTION SITE PAIN (Caller has had three other shots with Moderna with no serious reactions other than soreness at the sight). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19) and INJECTION SITE PAIN (Caller has had three other shots with Moderna with no serious reactions other than soreness at the sight) outcome was unknown.        For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.   This case was linked to MOD-2023-749767 (Patient Link).
Age: 0.42
Sex: F
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: 5-month-old was administered Hep A vaccine by mistake.
Age: 70.0
Sex: F
Vaccine: FLUA4
Symptoms: Injected limb mobility decreased, Joint injection, Pain, Pain in extremity, Product administered at inappropriate site
Clinical narrative: After receiving the vaccine, my arm pain increased in pain until I could not even lift my arm. I noticed he bandaid was very high up on my arm, really at my shoulder. I took photos the next morning. It has not been a little over a month and I still have pain when I use my left arm in a certain way, such as putting my bra on and putting shirts on and off. As well, it hurts when I roll over at night. The pain intensifies at times and I?m not sure why. Some days I?m almost in tears and other days I hardly notice except when getting dressed or rolling over in bed.
Age: 70.0
Sex: F
Vaccine: FLUA4
Symptoms: Rotator cuff syndrome, X-ray limb abnormal
Clinical narrative: After receiving the vaccine, my arm pain increased in pain until I could not even lift my arm. I noticed he bandaid was very high up on my arm, really at my shoulder. I took photos the next morning. It has not been a little over a month and I still have pain when I use my left arm in a certain way, such as putting my bra on and putting shirts on and off. As well, it hurts when I roll over at night. The pain intensifies at times and I?m not sure why. Some days I?m almost in tears and other days I hardly notice except when getting dressed or rolling over in bed.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Confusional state, Decreased appetite, Fatigue
Clinical narrative: Patient presented to the hospital for evaluation of confusion, increasing tremors, loss of appetite, and fatigue. Patient tested positive for Covid-19, diagnosed with Covid-19 pneumonia. Patient was not a candidate for Remdesivir since her GFR is less than 30. Patient was on oxygen and was able to wean off to room air. Patient was discharged to SNU.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Glomerular filtration rate, SARS-CoV-2 test positive, Tremor
Clinical narrative: Patient presented to the hospital for evaluation of confusion, increasing tremors, loss of appetite, and fatigue. Patient tested positive for Covid-19, diagnosed with Covid-19 pneumonia. Patient was not a candidate for Remdesivir since her GFR is less than 30. Patient was on oxygen and was able to wean off to room air. Patient was discharged to SNU.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Anticoagulant therapy, COVID-19, Condition aggravated, Death
Clinical narrative: Patient admitted with NSTEMI, covid infection with superimposed bacterial pneumonia. Received IV Rocephin and doxycycline, completed IV Remdesivir, initiated Baricitinib planned x 14 days planned but held at discharge. He was fully anticoagulated with Lovenox for 3 days per Cardiology for NSTEMI and transitioned to lovenox. S/p high dose steroid; planned to taper but will hold at discharge. He had worsening Acute metabolic encephalopathy, on top of alzheimer dementia due to all acute and chronic issues above and continued to decline. Family opted for hospice. Patient was transitioned to inpatient hospice unit. Patient passed away 1.21.22
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Metabolic encephalopathy, Pneumonia bacterial, Superinfection
Clinical narrative: Patient admitted with NSTEMI, covid infection with superimposed bacterial pneumonia. Received IV Rocephin and doxycycline, completed IV Remdesivir, initiated Baricitinib planned x 14 days planned but held at discharge. He was fully anticoagulated with Lovenox for 3 days per Cardiology for NSTEMI and transitioned to lovenox. S/p high dose steroid; planned to taper but will hold at discharge. He had worsening Acute metabolic encephalopathy, on top of alzheimer dementia due to all acute and chronic issues above and continued to decline. Family opted for hospice. Patient was transitioned to inpatient hospice unit. Patient passed away 1.21.22
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Cardiac failure acute, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patient presented with worsening SOB and orthopnea.  Patient was admitted with a diagnosis of acute respiratory failure with hypoxia due to acute COPD exacerbation and acute on chronic heart failure. He was treated with IV ceftriaxone, IV Lasix.  He was also found to have COVID-19 pneumonia and elevated LFT.  He was treated with supplemental oxygen, bronchodilators, steroids.  Patient's symptoms had improved significantly and is off oxygen and was discharged to SNU.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypoxia, Liver function test increased, Orthopnoea
Clinical narrative: Patient presented with worsening SOB and orthopnea.  Patient was admitted with a diagnosis of acute respiratory failure with hypoxia due to acute COPD exacerbation and acute on chronic heart failure. He was treated with IV ceftriaxone, IV Lasix.  He was also found to have COVID-19 pneumonia and elevated LFT.  He was treated with supplemental oxygen, bronchodilators, steroids.  Patient's symptoms had improved significantly and is off oxygen and was discharged to SNU.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Dyspnoea, Pneumonia, Positive airway pressure therapy
Clinical narrative: Patient presented to hospital with a chief complaint of Shortness Of Breath (EMS patient on NRB 15LPM with shortness of breath from home, recently hospitalized for pnumonia) and was admitted for COVID-19. Patient was diagnosed with acute hypoxic respiratory failure secondary to Covid. Procalcitonin elevated- started on cefepime and vancomycin - as well as Zithromax for atypical coverage. Was initially on high-flow nasal cannula and bilevel positive airway pressure p.r.n. - now on nasal cannula.   She is out of the window for remdesivir. Patient returned to home with resumption of home health services.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin increased
Clinical narrative: Patient presented to hospital with a chief complaint of Shortness Of Breath (EMS patient on NRB 15LPM with shortness of breath from home, recently hospitalized for pnumonia) and was admitted for COVID-19. Patient was diagnosed with acute hypoxic respiratory failure secondary to Covid. Procalcitonin elevated- started on cefepime and vancomycin - as well as Zithromax for atypical coverage. Was initially on high-flow nasal cannula and bilevel positive airway pressure p.r.n. - now on nasal cannula.   She is out of the window for remdesivir. Patient returned to home with resumption of home health services.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Dyspnoea, Fall, General physical health deterioration
Clinical narrative: Patient was Admitted with history of falls and worsening hypoxia.  Tested positive COVID-19 infection.  Patient had COVID-19 infection with pneumonia.  Patient condition slowly declined.  On 2/2/22, Patient wanted to stop all aggressive medical measures as she was having significant symptoms of dyspnea.  Patient placed on lorazepam and morphine  For symptom control.  Overnight patient condition has declined further.  Patient is appropriate for admission to inpatient hospice.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Patient was Admitted with history of falls and worsening hypoxia.  Tested positive COVID-19 infection.  Patient had COVID-19 infection with pneumonia.  Patient condition slowly declined.  On 2/2/22, Patient wanted to stop all aggressive medical measures as she was having significant symptoms of dyspnea.  Patient placed on lorazepam and morphine  For symptom control.  Overnight patient condition has declined further.  Patient is appropriate for admission to inpatient hospice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Metabolic encephalopathy
Clinical narrative: Patient admitted for Covid-19 pneumonia and acute metabolic encephalopathy in the setting of Covid-19 infection. Patient received Rocephin, Remdesivir, Decadron IV. Patient was discharged home.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Chest discomfort, Conjunctival oedema, Electrocardiogram, Headache
Clinical narrative: Reported symptoms: 1000488:CHEST PRESSURE SENSATION OF; 10014218:EDEMA CONJUNCTIVAL; 10016558:FEVER; 10019211:HEADACHE; 10020772:HYPERTENSION; 10028411:MYALGIA; 10042680:SWELLING ARM;  Narrative: Patient was instructed to seek medical advice/ TX. Patient instructed to go to ER immediately for evaluation, EKG, chest x-ray and appropriate treatment/evaluation. Also, per PCP recommendation, advised dose of Motrin 200mg which he has at home x 1 in setting of inflammation and see if any improvement.   Other Relevant HX:  Other:  mild chest pressure on the left side, with mild  swelling on the left arm pit and pectoral area and left eye mild swelling
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Inflammation, Myalgia, Peripheral swelling, Pyrexia
Clinical narrative: Reported symptoms: 1000488:CHEST PRESSURE SENSATION OF; 10014218:EDEMA CONJUNCTIVAL; 10016558:FEVER; 10019211:HEADACHE; 10020772:HYPERTENSION; 10028411:MYALGIA; 10042680:SWELLING ARM;  Narrative: Patient was instructed to seek medical advice/ TX. Patient instructed to go to ER immediately for evaluation, EKG, chest x-ray and appropriate treatment/evaluation. Also, per PCP recommendation, advised dose of Motrin 200mg which he has at home x 1 in setting of inflammation and see if any improvement.   Other Relevant HX:  Other:  mild chest pressure on the left side, with mild  swelling on the left arm pit and pectoral area and left eye mild swelling
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Intensive care, Oxygen saturation decreased, Positive airway pressure therapy
Clinical narrative: He came in with shortness of breath, moderate in intensity  for 2 days at nursing home ,oxygen saturation was noted to be low at 79%.  No chest pain.  Was admitted to  ICU.  On BiPAP. He was admitted ,placed on empiric antibiotics ,dexamethasone and remdesivir.Hospice was consulted and patient transitioned to IP hospice.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Pyrexia, Tachycardia
Clinical narrative: Patient was admitted for COVID related symptoms including fever, chills, cough, headache.  She had maternal and fetal tachycardia and maternal fever on admission.  She underwent the sepsis protocol.  All her symptoms resolved and she was afebrile >24 hours.  She was stable prior to discharge.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Local reaction at site of vaccine administration, noted to be itchy and red
Age: 62.0
Sex: M
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt received fluzone hd vs flublock or fluzone, no adverse effects reported
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Swelling, Urticaria
Clinical narrative: First three COVID doses were all Pfizer First moderna  Onset of LA local swelling and hives, painful, approx 20hrs after vaccine administration. No systemic sx
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Limb mass, Mobility decreased, Peripheral swelling, Urticaria
Clinical narrative: First three COVID doses were all Pfizer First moderna  Onset of LA local swelling and hives, painful, approx 20hrs after vaccine administration. No systemic sx
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Swelling, Urticaria
Clinical narrative: Per patient report: I received the covid vaccine on Friday November 17, 2023. I felt fine after receiving the vaccine until the next day I woke up to my arm swollen in severe pain. I could barely lift my arm. I have a huge lump and bruise on my arm and yesterday I broke out in hives and it's currently still painful.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Limb mass, Mobility decreased, Peripheral swelling, Urticaria
Clinical narrative: Per patient report: I received the covid vaccine on Friday November 17, 2023. I felt fine after receiving the vaccine until the next day I woke up to my arm swollen in severe pain. I could barely lift my arm. I have a huge lump and bruise on my arm and yesterday I broke out in hives and it's currently still painful.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dizziness, Pyrexia
Clinical narrative: Admitted with generalized weakness, lighteadedness and fevers, found to have covid-19 virus infection.   She was started on remdesivir to prevent any worsening.  Of note, patient was requiring 2L of nasal cannula to maintain her oxygen levels.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Delirium, Mental status changes, Oxygen saturation decreased
Clinical narrative: came into the hospital with COVID-19 pneumonia and acute hypoxic respiratory failure his O2 saturations were 80% on room air on arrival.  He was admitted to the hospital placed on isolation and was initially on 7-8 L oxygen nasal cannula he was aggressively treated with remdesevir, Actemra, antibiotics, Lovenox, seen by ID in the hospital gradually improved with decreasing O2 he was also seen by Neurology due to altered mental status.  Stroke was ruled out they recommended supportive care and treatment of delirium with p.r.n. medications
Age: 81.0
Sex: M
Vaccine: RSV
Symptoms: Atrial fibrillation, Condition aggravated, Polyuria
Clinical narrative: I had an episode of A fib accompanied by polyuria. I have had these episodes  for many years and I suspect it is just coincidence that it happened after the RSV shot.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pain, Lymph node pain, Lymphadenopathy
Clinical narrative: Red and tender at vaccination site Swollen lymph nodes in armpit that are tender to the touch
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood sodium decreased, COVID-19, Diarrhoea, Dyspnoea
Clinical narrative: Patient is a 82 y.o. female who presented with covid 19. Symptoms started 3 days prior to arrival, and consisted of SOB, N/V/D. She was progressively weakening, so her family brought her in. She was found to have profound hyponatremia with sodium 112. Nephrology was consulted, she received initially some hypertonic saline and then NS, with which she had. GI and respiratory symptoms resolved. She tolerated diet. She was cleared by nephrology, and discharged home in stable condition with instructions for outpatient follow up.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Hyponatraemia, Nausea, Respiratory symptom, Vomiting
Clinical narrative: Patient is a 82 y.o. female who presented with covid 19. Symptoms started 3 days prior to arrival, and consisted of SOB, N/V/D. She was progressively weakening, so her family brought her in. She was found to have profound hyponatremia with sodium 112. Nephrology was consulted, she received initially some hypertonic saline and then NS, with which she had. GI and respiratory symptoms resolved. She tolerated diet. She was cleared by nephrology, and discharged home in stable condition with instructions for outpatient follow up.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Confusional state, Cough, Decreased appetite
Clinical narrative: Patient is a 81 y.o. female who came in with the chief complaint of confusion, cough, tiredness, decreased appetite, secondary to covid 19, her symptoms improved with symptomatic management but was debilitated from hospital stay. Pt/ot was consulted and they recommended SNF , she will be discharged to SNF.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Patient is a 81 y.o. female who came in with the chief complaint of confusion, cough, tiredness, decreased appetite, secondary to covid 19, her symptoms improved with symptomatic management but was debilitated from hospital stay. Pt/ot was consulted and they recommended SNF , she will be discharged to SNF.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Dementia, Hypophagia
Clinical narrative: presents with generalized weakness.  Admitted with COVID-19 pneumonia  And acute pulmonary embolus. Patient noted to have altered mental status thought to be due to toxic metabolic encephalopathy in the setting of COVID-19.   Seen by infectious disease and treated with remdesivir, antibiotics and steroids.  She was started on Eliquis for pulmonary embolus.  Respiratory status has improved and she is stable on room air.  Patient had poor p.o. intake likely related to dementia and COVID.  Seen by dietitian and started on Clinimix. Diet has improved some and she is eating Less than 50% of  2 meals daily..  She was started on mirtazapine.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes, Pulmonary embolism, Toxic encephalopathy
Clinical narrative: presents with generalized weakness.  Admitted with COVID-19 pneumonia  And acute pulmonary embolus. Patient noted to have altered mental status thought to be due to toxic metabolic encephalopathy in the setting of COVID-19.   Seen by infectious disease and treated with remdesivir, antibiotics and steroids.  She was started on Eliquis for pulmonary embolus.  Respiratory status has improved and she is stable on room air.  Patient had poor p.o. intake likely related to dementia and COVID.  Seen by dietitian and started on Clinimix. Diet has improved some and she is eating Less than 50% of  2 meals daily..  She was started on mirtazapine.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Hypophagia, Illness, SARS-CoV-2 test positive
Clinical narrative: Presented with GLF related to "10 days of illness with minimal PO intake". Extreme weakness. Positive for Covid.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Dyspnoea, Faeces discoloured
Clinical narrative: Patient is a 77 y.o. female who presented with generalized weakness, cough, SOB, unable to make it to her hemodialysis.  Found to be COVID positive, requiring 2 L nasal cannula, was started on Decadron.  Patient was continued on hemodialysis during hospital course.  She was noted to have drop in hemoglobin as well as dark stools.  GI was consulted, she required 1 unit of packed red blood cell transfusion, H&H remained stable, recommended to have outpatient follow-up with Dr.  Patient was evaluated PT OT who recommended post acute, however patient refused and was discharged home with home health instead.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Haematocrit normal, Haemodialysis, Haemoglobin decreased, Red blood cell transfusion, SARS-CoV-2 test positive
Clinical narrative: Patient is a 77 y.o. female who presented with generalized weakness, cough, SOB, unable to make it to her hemodialysis.  Found to be COVID positive, requiring 2 L nasal cannula, was started on Decadron.  Patient was continued on hemodialysis during hospital course.  She was noted to have drop in hemoglobin as well as dark stools.  GI was consulted, she required 1 unit of packed red blood cell transfusion, H&H remained stable, recommended to have outpatient follow-up with Dr.  Patient was evaluated PT OT who recommended post acute, however patient refused and was discharged home with home health instead.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Cerebrovascular accident, Fibrin D dimer increased, SARS-CoV-2 test positive
Clinical narrative: Admitted for stroke, also positive for Covid. Elevated CRP and D-dimer, infectious disease consulted, treated with Decadron and heparin.
Age: 65.0
Sex: F
Vaccine: COVID19, FLU4, PNC20
Symptoms: Decreased appetite, Injection site pain, Injection site swelling, Injection site warmth, Lethargy
Clinical narrative: The patient got PCV20 in the right deltoid on 10/25/23, then experienced severe swelling and pain at the injection site. The arm was hot to touch. Other symptoms included lethargy, loss of appetite, and inability to raise her arm. The patient then went to the emergency department in 10/28/23 after symptoms were not improving, and was treated with SMZ/TMP double strength, 1 tablet twice daily for 7 days. As of 11/9/23, the patient was fully recovered. The patient also received her flu and covid vaccines on the same day in her left arm and had no local side effects in that arm.
Age: 65.0
Sex: F
Vaccine: COVID19, FLU4, PNC20
Symptoms: Mobility decreased
Clinical narrative: The patient got PCV20 in the right deltoid on 10/25/23, then experienced severe swelling and pain at the injection site. The arm was hot to touch. Other symptoms included lethargy, loss of appetite, and inability to raise her arm. The patient then went to the emergency department in 10/28/23 after symptoms were not improving, and was treated with SMZ/TMP double strength, 1 tablet twice daily for 7 days. As of 11/9/23, the patient was fully recovered. The patient also received her flu and covid vaccines on the same day in her left arm and had no local side effects in that arm.
Sex: M
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered was 2 days expired (expired 11/18/2023  -- date of admin 11/20/2023). No further reactions noted at this time.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash macular
Clinical narrative: Red blotchy rash on chest and upper back.
Age: 14.0
Sex: M
Vaccine: MMRV
Symptoms: No adverse event, Product use issue
Clinical narrative: There was no adverse reaction. MMRV administered as a combined dose instead of 2 separate doses due to the age of the child.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Lymphadenopathy, Pain, Pruritus, Skin warm
Clinical narrative: 3 local hives and swollen superficial cervical lymph nodes, that are itchy, tender/painful, hot to touch, erythematous
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Tenderness, Urticaria
Clinical narrative: 3 local hives and swollen superficial cervical lymph nodes, that are itchy, tender/painful, hot to touch, erythematous
Age: 1.42
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Flu vaccine ordered and given to patient but had already been administered in 9/2023.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Arthritis, Cerebrovascular accident, Computerised tomogram, Dry skin
Clinical narrative: She got her vaccine, afterwards she started to studdard about 1 1/2 months after the vaccine.  When she try to talk sometimes it is very difficult, she has to calm herself down and try to talk slower but she never in her lifetime had trouble talking.  She went to her doctor and went to several doctors and has an appointment now with a Neurologist in April of 2024.  When she went to her PCP she told her that she had a minor stroke, and she asked her when and she said that nothing occurred recently.  She didn't know the timeframe of it.  She said that if she had a stroke why wasn't she studdaring then, and she did not know.  She had an MRI and possibly a CAT scan and several other tests, and that's when her PCP determined she had a stroke.  She saw a cardiologist, an orthopedist, and many other tests.  She is on Meloxicam for inflammation for her knee pain which they said was due to arthritis.    Her skin is also very dry, and has never had skin that dry before.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inflammation, Laboratory test, Magnetic resonance imaging, Speech disorder
Clinical narrative: She got her vaccine, afterwards she started to studdard about 1 1/2 months after the vaccine.  When she try to talk sometimes it is very difficult, she has to calm herself down and try to talk slower but she never in her lifetime had trouble talking.  She went to her doctor and went to several doctors and has an appointment now with a Neurologist in April of 2024.  When she went to her PCP she told her that she had a minor stroke, and she asked her when and she said that nothing occurred recently.  She didn't know the timeframe of it.  She said that if she had a stroke why wasn't she studdaring then, and she did not know.  She had an MRI and possibly a CAT scan and several other tests, and that's when her PCP determined she had a stroke.  She saw a cardiologist, an orthopedist, and many other tests.  She is on Meloxicam for inflammation for her knee pain which they said was due to arthritis.    Her skin is also very dry, and has never had skin that dry before.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dysuria, Inflammatory marker test, Pollakiuria, Tremor
Clinical narrative: This is a 90 y.o. with hx of HTN, GERD, dementia who presented with the above complaints.  Husband at bedside.  Pt has been having tremors with generalized weakness since yesterday.  She has been having urinary frequency with pain.  No fever or chills noted.  She has not had a cough or congestion. No sob,chest pain, abdominal pain, nausea, vomiting, or diarrhea. Remained on room air. Initially no anti viral indicated per ID ; however started on Remdesvir and low dose steroid  per ID on 2/13 for worsening inflammatory markers  Completed IV Remdesivir x 5 days  Complete steroid po outpatient
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cataract, Vision blurred
Clinical narrative: Blurry left eye after injection. Cleared  up after a few days. Contracted COVID 2nd time August 2023 - left eye blurry again.  Cleared up somewhat in a few days.
Age: 14.0
Sex: F
Vaccine: COVID19, FLU4, HEPA, HPV9
Symptoms: Syncope
Clinical narrative: Faited
Age: 71.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Back pain, Muscle spasms, Musculoskeletal stiffness
Clinical narrative: One day after the 2 vaccinations (Nov 16, 2023 09:30EDT) I developed a lower right back pain. For 2 days after that I was in pain standing, with spasms developing after 15 minutes of standing. In bed I was fine, tight but no pain. Pain resolved after the two 2 days.
Age: 83.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Wrong product administered
Clinical narrative: Patient requested regular flu vaccine but was administered the high dose vaccine.
Age: 60.0
Sex: M
Vaccine: MNQ
Symptoms: Underdose
Clinical narrative: Only 3 of 4 Menveo components administered to patient.
Age: 69.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Cough, Myalgia, Pyrexia, Respiratory tract congestion, Sinus headache
Clinical narrative: Sinus headache, cough, mild fever sore muscles, congestion.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Cough, Diarrhoea, Lip swelling, Paraesthesia
Clinical narrative: TINGLING IN FACE AND ARMS, PERIORBITAL EDEMA, NEXT DAY FACIAL SWELLING, COUGH, VOMITING, DIARRHEA, CHILLS, LIPS FELT SWOLLEN
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Periorbital oedema, Swelling face, Vomiting
Clinical narrative: TINGLING IN FACE AND ARMS, PERIORBITAL EDEMA, NEXT DAY FACIAL SWELLING, COUGH, VOMITING, DIARRHEA, CHILLS, LIPS FELT SWOLLEN
Age: 8.0
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse reactions noted. Patient is out of age range for Pentacel.
Age: 66.0
Sex: M
Vaccine: RSV
Symptoms: Arthralgia, Chest X-ray abnormal, Neck pain, Pain, Painful respiration
Clinical narrative: About 6 hours (9pm) after receiving vaccine started to experience sharp pain when breathing around right rib cage later radiating into right shoulder/neck area. Extreme pain while trying to sleep. Went to urgent care 11am 11-18-2023.  X-ray taken, slight scarring in lung. Prescribed Ibuprofen for pain and antibiotic Azithromycin 250 MG.
Age: 66.0
Sex: M
Vaccine: RSV
Symptoms: Pulmonary fibrosis
Clinical narrative: About 6 hours (9pm) after receiving vaccine started to experience sharp pain when breathing around right rib cage later radiating into right shoulder/neck area. Extreme pain while trying to sleep. Went to urgent care 11am 11-18-2023.  X-ray taken, slight scarring in lung. Prescribed Ibuprofen for pain and antibiotic Azithromycin 250 MG.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody, Brain natriuretic peptide, Cardiac imaging procedure normal, Cardiomyopathy, Catheterisation cardiac normal
Clinical narrative: INITIAL SUBCLINICAL/UNRECOGNIZED MYOCARDITIS LED TO COVID-19 VACCINE INDUCED CARDIOMYOPATHY RESULTING IN HEART FAILURE WITH REDUCED EJECTION FRACTION 20% AND PULMONARY EDEMA
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diuretic therapy, Echocardiogram normal, Ejection fraction decreased, Galectin-3 test, Left ventricular failure
Clinical narrative: INITIAL SUBCLINICAL/UNRECOGNIZED MYOCARDITIS LED TO COVID-19 VACCINE INDUCED CARDIOMYOPATHY RESULTING IN HEART FAILURE WITH REDUCED EJECTION FRACTION 20% AND PULMONARY EDEMA
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Pulmonary oedema, SARS-CoV-2 test, Troponin
Clinical narrative: INITIAL SUBCLINICAL/UNRECOGNIZED MYOCARDITIS LED TO COVID-19 VACCINE INDUCED CARDIOMYOPATHY RESULTING IN HEART FAILURE WITH REDUCED EJECTION FRACTION 20% AND PULMONARY EDEMA
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Fatigue, Injection site induration, Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: Intense muscle aches, severe fatigue, red, swollen, lump (approximately 1" diameter) at injection site all within 6 hours of vax. Most symptoms passed after approximately 32 hours, however, injection site reaction continues to grow (6" diameter) and is hard, itchy, swollen, and hot to the touch.
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Injection site warmth, Myalgia
Clinical narrative: Intense muscle aches, severe fatigue, red, swollen, lump (approximately 1" diameter) at injection site all within 6 hours of vax. Most symptoms passed after approximately 32 hours, however, injection site reaction continues to grow (6" diameter) and is hard, itchy, swollen, and hot to the touch.
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Erythema, Pain, Skin haemorrhage, Swelling
Clinical narrative: redness, pain, swelling, skin blisters that lasted 1 week
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Please see full narrative on Continuation page.
Age: 18.0
Sex: F
Vaccine: FLU4, MENB
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling and redness at the site of injection lasting 4 days.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Fatigue, Myalgia
Clinical narrative: Fatigue.   Muscle ache throughout body. Temperature 104 degrees F.
Age: 80.0
Sex: M
Vaccine: RSV
Symptoms: Chills, Diarrhoea, Headache, Pain, Pyrexia
Clinical narrative: Diarrhea, chills, fever, headache and body aches for 7 days now
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysstasia, Fall, Feeling cold, Mobility decreased
Clinical narrative: She got her vaccine, went to Store and had the vaccine, the shot wasn't painful at all, and felt that it went well . She was OK the rest of the day until late evening when she normally starts to get ready for bed, and she started shivering.  Her teeth were shattering, she was freezing, and her husband kept piling on her blankets.  She did have a fever that was low at 100._.   She walks around the house with a walker as she has a bad back, and bad knees, and was using the walker and made it to the bathroom and started getting back out and right before she got to her chair her legs were so weak that they gave out.  She fell on the floor, and he had to call 911 to help get her up.  This is also the same thing that happened last year when she took her vaccine.  She is still weak and can barely stand up, and is now using a wheelchair to navigate around the house.    She has not called her doctor.  Every day she gets a tiny bit better where she can stand up long enough to get from her wheelchair to her lift chair and back.  She is not running any fever at this time, just the weakness that she is having.    When she had this last year it took several days for the symptoms to get better.  She states she will not go through this again and will not take another COVID vaccine.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Walking aid user, Wheelchair user
Clinical narrative: She got her vaccine, went to Store and had the vaccine, the shot wasn't painful at all, and felt that it went well . She was OK the rest of the day until late evening when she normally starts to get ready for bed, and she started shivering.  Her teeth were shattering, she was freezing, and her husband kept piling on her blankets.  She did have a fever that was low at 100._.   She walks around the house with a walker as she has a bad back, and bad knees, and was using the walker and made it to the bathroom and started getting back out and right before she got to her chair her legs were so weak that they gave out.  She fell on the floor, and he had to call 911 to help get her up.  This is also the same thing that happened last year when she took her vaccine.  She is still weak and can barely stand up, and is now using a wheelchair to navigate around the house.    She has not called her doctor.  Every day she gets a tiny bit better where she can stand up long enough to get from her wheelchair to her lift chair and back.  She is not running any fever at this time, just the weakness that she is having.    When she had this last year it took several days for the symptoms to get better.  She states she will not go through this again and will not take another COVID vaccine.
Age: 65.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccinator gave a Moderna Vaccine to patient past the vaccines beyond use date (BUD). Patient was observed for a period of 15 min after injection with no adverse reaction. Vaccinator was re educated on checking all expiration dates and BUD of Vaccines before admnistering.
Age: 0.17
Sex: M
Vaccine: RSV
Symptoms: Underdose
Clinical narrative: None. Just given incorrect dosage, gave 50mg instead of 100mg.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Bronchial wall thickening, COVID-19, Chronic obstructive pulmonary disease
Clinical narrative: Admitted: 10/2/2023 Discharge Date: 10/05/23    PCP Handoff    Recommended Outpatient Testing Follow-up with PCP in 1 to 2 weeks   Results Pending At Discharge    Blood Culture Aerobic/Anaerobic Preliminary result Blood Culture Aerobic/Anaerobic Preliminary result      Clinical Summary   Patient is a 87 y.o. female patient of MD with history of C. Diff, HTN, HFpEF, COPD, CVA, seizure disorder presented to Hospital with cough and shortness of breath.   Acute respiratory failure with hypoxia COPD with possible exacerbation Suspected secondary to recent COVID-19 infection, possible developing secondary lung injury versus secondary bacterial pneumonia. Had COVID symptoms in early September, treated with Paxlovid though was never tested for. COVID (husband tested positive) and did improve with worsening over 5 days prior to admission Treated with medrol dose pack and azithromycin as outpatient without improvement prior to admission. CTPA on admission with interstitial and ground-glass infiltrates are most pronounced in the right lung; bilateral bronchial wall thickening is suggestive of bronchitis. Respiratory PCR,urinary antigens for Legionella and strep pneumo--unremarkable except for COVID. Given levaquin in ED, transitioned to ceftriaxone/azithromycin given higher risk of C. Diff with flouroquinolones.  With patient having diarrhea, discontinued Rocephin and continued azithromycin.  Continued Zithromax to complete the course at discharge. Started decadron for COVID and COPD exacerbation and continued at discharge. Checked O2 requirement prior to discharge.  Qualified for 2 L of oxygen ATC. Patient to follow-up with PCP in 1 to 2 weeks     Recent COVID-19 viral infection Date of onset of symptoms: early September initially, then improved, then 5 days prior to admission Symptoms present on admission: shortness of breath, cough Date of covid positive test: was not tested in early September but treated with Paxlovid due to husband being positive; tested positive on admission 10/2 Vaccination status: vaccinated Imaging: CTPA as above Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: steroids Consultants following: n/a Anticipated special isolation end date: given unclear timing, remain in isolation 5 additional days   History of recurrent C. Diff infection With prior fulminant infection in Sep 2022, prior FMT Prophylactic PO vancomycin while on antibiotics Patient started having diarrhea in the hospital but stool C. difficile negative   Chronic anemia Baseline hemoglobin 9 to 10 g/dL Admit Hb 9.2> 8.2 most likely due to hemodilution On B12 and iron supplementation   History of CVA With some residual left sided weakness Continue home plavix and statin   Seizure disorder Continue home Keppra   HTN Home Rx: Lisinopril 5 mg daily.  BP was running low.  Discontinued lisinopril.  May restart as an outpatient based on BP readings   HFpEF, chronic Continue home furosemide 20 mg daily